Elis: Disclosure Of Trading In Own Shares Occured From August 25 To August 26, 2025

2025-08-28 02:01:04

(MENAFN- GlobeNewsWire - Nasdaq) Disclosure of trading in own shares occurred
from August 25 to August 26, 2025

Saint-Cloud, August 28, 2025

In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from August 25 to August 26, 2025 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025 and announced on March 6, 2025:

Aggregated presentation:

Issuer name	Issuer code (LEI)	Transaction date	ISIN Code	Daily total Volume (in number of shares)	Daily weighted average price of shares acquired (in euros)	Platform (MIC Code)
ELIS SA	969500UX71LCE8MAY492	08/25/2025	FR0012435121	17,500	25.1511	XPAR
ELIS SA	969500UX71LCE8MAY492	08/25/2025	FR0012435121	20,430	24.8829	DXE
ELIS SA	969500UX71LCE8MAY492	08/26/2025	FR0012435121	55,967	23.4424	XPAR
ELIS SA	969500UX71LCE8MAY492	08/26/2025	FR0012435121	24,500	23.3788	DXE
ELIS SA	969500UX71LCE8MAY492	08/26/2025	FR0012435121	5,000	23.1154	TQE
ELIS SA	969500UX71LCE8MAY492	08/26/2025	FR0012435121	6,308	23.1740	AQE
	Total	129,705	23.8622

The purpose of the own shares purchase operations is (i) to cover maturing performance share plans and to allocate free shares to employees as part of the contribution to the Elis for All 2025 international employee shareholding plan, and (ii) to be cancelled in accordance with the 26th resolution of the Combined General Meeting of May 22, 2025.

Contacts

Nicolas Buron
Director of Investor Relations, Financing & Treasury
Phone: + 33 (0)1 75 49 98 30 - ...

Charline Lefaucheux
Investor Relations
Phone: + 33 (0)1 75 49 98 15 - ...

Attachment

Elis - Disclosure of trading in own shares occured from August 25 to August 26, 2025

MENAFN28082025004107003653ID1109986039

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.